Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;1(3):398-413.
doi: 10.1007/s12072-007-9010-9. Epub 2007 Sep 11.

Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment

Shiv Kumar Sarin  1 , Ashish Kumar, Yogesh Kumar Chawla, Sanjay Saran Baijal, Radha Krishna Dhiman, Wasim Jafri, Laurentius A Lesmana, Debendranath Guha Mazumder, Masao Omata, Huma Qureshi, Rizvi Moattar Raza, Peush Sahni, Puja Sakhuja, Mohammad Salih, Amal Santra, Barjesh Chander Sharma, Praveen Sharma, Gamal Shiha, Jose Sollano; Members of the APASL Working Party on Portal Hypertension
Affiliations

Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment

Shiv Kumar Sarin et al. Hepatol Int. 2007 Sep.

Abstract

The Asian Pacific Association for the Study of the Liver (APASL) Working Party on Portal Hypertension has developed consensus guidelines on the disease profile, diagnosis, and management of noncirrhotic portal fibrosis and idiopathic portal hypertension. The consensus statements, prepared and deliberated at length by the experts in this field, were presented at the annual meeting of the APASL at Kyoto in March 2007. This article includes the statements approved by the APASL along with brief backgrounds of various aspects of the disease.

PubMed Disclaimer

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15925423', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15925423/'}]}
    2. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167–76. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16761994', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16761994/'}]}
    2. Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M et al. Members of the APASL Working Party on Portal Hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006;26:512–9. - PubMed
    1. Centre for Evidence Based Medicine. Department of Primary Care, Old Road Campus, Headington, Oxford, OX3 7LF, UK. http://www.cebm.net/index.aspx?o=1025.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1476958', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1476958/'}, {'type': 'PubMed', 'value': '5833586', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/5833586/'}]}
    2. Mikkelsen WP, Edmondson HA, Peters RL, Redeker AG, Reynolds TB. Extra- and intra-hepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg 1965;162:602–20. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8578318', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8578318/'}]}
    2. Bioulac-Sage, Le Bail B, Bernard PH, Balabaud C. Hepatoportal sclerosis. Semin Liver Dis 1995;15:329–39. - PubMed

LinkOut - more resources